All Blogs
All Stories
About Us
Science & Technology
Pipeline
Investors & Media
Contact Us
AI Search
Sign Up

Lead Program in GBA-Parkinson’s Disease

Lead Program in GBA-Parkinson’s Disease

Share

Download: Lead Program in GBA-Parkinson’s Disease

Share

Related Posts

When is Parkinson’s Awareness Month and Day?

Unveiling the Potential of GBA: A Key Player in Parkinson’s Disease Precision

Gain Therapeutics presents at the Jefferies Conference 2022

Gain Therapeutics announces issuance of two new pct patents covering gba and galc modulator

KOL/Analyst Event

Latest Posts

Gain Therapeutics Reports Positive Results from Single Ascending Dose (SAD) Part of Phase 1 Clinical Trial of GT-02287 for GBA1 Parkinson’s Disease
Medicine That Matters: An Interview with Jonas Hannestad, MD, PhD – Chief Medical Officer
When is Parkinson’s Awareness Month and Day?
Fireside Revelations at Discovery Day, Dallas: Eric Richman’s Vision for Treatment of Neurodegenerative Diseases
Unveiling the Potential of GBA: A Key Player in Parkinson’s Disease Precision

©2022 Gain Therapeutics, Inc

All Blogs
All Stories
About Us
Science & Technology
Pipeline
Investors & Media
Contact Us
AI Search
Sign Up

Menu

All Blogs
All Stories
About Us
Science & Technology
Pipeline
Investors & Media
Contact Us
AI Search
Sign Up

Follow Us

Twitter Linkedin

All Blogs
All Stories
About Us
Science & Technology
Pipeline
Investors & Media
Contact Us
AI Search
Sign Up